Insulin showdown: which works better for kids with diabetes in poor regions?
Disease control
Completed
This study tested whether a newer insulin (glargine) is safer and better at controlling blood sugar than standard human insulin in 400 youth aged 7-25 with type 1 diabetes living in low-resource settings. Participants used continuous glucose monitors to track their levels over 6-…
Phase: PHASE4 • Sponsor: Jing Luo • Aim: Disease control
Last updated May 22, 2026 13:51 UTC